[1]
Shulgau, Z., Kamyshanskiy , Y. and Gulyayev, A. 2023. POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD. Eurasian Journal of Applied Biotechnology. 1 (Apr. 2023), 3–26. DOI:https://doi.org/10.11134/btp.1.2023.1.